Mylan N.V. (MYL)

pos +0.00
Today's Range: 41.31 - 42.73 | MYL Avg Daily Volume: 0
Last Update: 04/29/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $42.60
52 Week Range: $37.59 - $74.66
Oustanding Shares: 490,688,000,000
Market Cap: 21,202,974,400
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for MYL:
Revenue 0.00B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $0.75 $1.17 $4.90 $5.71
Number of Analysts 7 6 9 9
High Estimate $0.79 $1.22 $4.98 $6.16
Low Estimate $0.71 $1.08 $4.82 $5.08
Prior Year $0.70 $0.91 $4.30 $4.90
Growth Rate (Year over Year) 7.14% 28.21% 13.90% 16.58%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat. 
Other companies have suffered following the debacle.
Other companies have suffered following the debacle.
I continue to add to my holdings incrementally. 
Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.
David Einhorn is a man of many talents, including playing poker -- and watching where he stacks his chips investment-wise is a worthwhile endeavor, too.
The market looks like it is expecting a significant domestic contraction in 2016, but I don't see it.
The year has not started the way most pundits and prognosticators had envisioned.
Mylan and Endo International look like bargains at current prices.
Don't catch falling knives, and don't ignore dividends.

Columnist Conversations

Up in an hour or so! Enjoy your weekend and thanks for reading my Diary.
HIG, the object of my affection today, rips +$0.50 higher in the last few minutes of trading. Just wishing and...
Rolling SDS long sale proceeds into SPY/QQQ $2.5 billion to buy at month end, aiding markets. Trying to be opp...
Money Management firm Waddell & Reed (WDR) is having a bad year. The news is reflected in the price which ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.